SCHEMBL15436313

SCHEMBL15436313

C=CC[C@H](CCN(C(=O)O)[C@@H](C)c1ccc(Br)cc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.40
ALOX5 P09917 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
PMP22 Q01453 1/20 0.38
CNR1 P21554 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
LMNA P02545 2/20 0.36
ALDH1A1 P00352 2/20 0.36
OPRM1 P35372 2/20 0.36
CHRM2 P08172 1/20 0.36
HTR1A P08908 1/20 0.36
ADRA2A P08913 1/20 0.36
CHRM1 P11229 1/20 0.36
DRD1 P21728 1/20 0.36
TBXA2R P21731 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
DRD3 P35462 1/20 0.36
SLC6A3 Q01959 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13538362 1.00 CYP2C19 (0.40) CYP2C19ALOX5MEN1KMT2APMP22
SCHEMBL13538484 0.91 ALOX5 (0.37) CYP2C19ALOX5PMP22L3MBTL1
SCHEMBL13953564 0.86 TRPM8 (0.41) CYP2C19ALDH1A1
SCHEMBL13953597 0.85 ALOX5 (0.40) ALOX5MEN1KMT2APMP22CNR1
SCHEMBL13552165 0.84 ALDH1A1 (0.38) ALOX5MEN1KMT2APMP22CNR1
SCHEMBL13624935 0.84 ALOX5 (0.38) ALOX5MEN1KMT2APMP22CNR1
SCHEMBL15241497 0.84 ALOX5 (0.40) ALOX5MEN1KMT2APMP22CNR1
SCHEMBL15241454 0.82 ALOX5 (0.38) ALOX5MEN1KMT2APMP22CNR1
SCHEMBL13624952 0.82 ALOX5 (0.44) ALOX5MEN1KMT2APMP22CNR1
SCHEMBL21798469 0.82 ALOX5 (0.44) CYP2C19ALOX5MEN1KMT2APMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2687525-A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 Boehringer Ingelheim International GmbH (DE) 2014-01-22 EP disclosed